SOMAVERT: payments to doctors
Payments that named SOMAVERT as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $312K
- Providers
- 2,210
- Transactions
- 7,613
- Average per transaction
- $41
The per-transaction average — $41 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 2,210 providers the average total is $141, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Pfizer | $287,899 | 92.3% |
| PBG Puerto RICO LLC | $11,985 | 3.8% |
| Whitehall International Inc | $7,600 | 2.4% |
| Pfizer Canada Inc | $2,036 | 0.7% |
| Pfizer S.a.s. | $1,541 | 0.5% |
| Pfizer Pharmaceuticals LLC | $693 | 0.2% |